For example, IL-9 was specifically expressed by nasal NK/T-cell lymphoma cell lines, where it acted as an autocrine growth factor, suggesting that the IL-9 signaling pathway may be a new therapeutic target for NK/T-cell lymphoma [6]. Here, IL9 is linked to T-cell non-Hodgkin lymphoma.